HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

QYUNS-B

21.040

+0.6803.34%

Volume:612.62K

Turnover:13.11M

Market Cap:4.78B

PE:-12.57

High:22.120

Open:20.880

Low:20.200

Close:20.360

52wk High:36.500

52wk Low:5.950

Shares:227.07M

HK Float Shares:227.07M

Volume Ratio:0.64

T/O Rate:0.27%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.674

ROE:-68.26%

ROA:-10.67%

PB:19.28

PE(LYR):-12.57

PS:13.62

Loading ...

Overview Company News Filings

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 13% Again Following Strong H1 Performance and Major Investment from TruMed Fund

From Monoclonal to Bispecific Antibodies, From Domestic to Global: How QYUNS-B (02509) Becomes a New Benchmark in the Autoimmune Track?

Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 22% as H1 Revenue Soars with Significant Loss Reduction, Core Product R&D Progresses Smoothly

Qyuns Therapeutics' H1 Loss Narrows; Shares Rise 6%

MT Newswires Live

BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per Share

QYUNS-B (02509) Plans to Place 5 Million Shares at Approximately 10.95% Discount, Raising Net Proceeds of About HK$99 Million

Qyuns Therapeutics - to Issue 5 Mln Placing Shares at HK$20.0 per Share

THOMSON REUTERS

QYUNS-B (02509) Announces Interim Results with Revenue of RMB 206 Million, Up 359.69% YoY

BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 Million

Qyuns Therapeutics - Hy Revenue RMB206.5 Mln

THOMSON REUTERS

QYUNS-B (02509) Appoints Feng Zhiwei as Chief Independent Non-Executive Director

Qyuns Therapeutics' Psoriasis Drug Enters Phase III Trial

MT Newswires Live

Hong Kong Stocks Movement | QYUNS-B (02509) Surges Over 8% Intraday, Stock Price Accumulates Nearly 40% Gain in Past Month with Leading Position in Domestic Autoimmune Dual Antibody Layout

Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank; Shares Fall 1%

MT Newswires Live

BRIEF-Qyuns Therapeutics Subscribes To Wealth Management Products With Principal Amount RMB60 Mln

Qyuns Therapeutics Co. Ltd. Conducted Annual General Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02509/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":21.04,"timestamp":1763107691009,"preClose":20.36,"halted":0,"volume":612617,"delay":0,"floatShares":227071600,"shares":227071600,"eps":-1.6741191529099049,"marketStatus":"Market Closed","change":0.68,"latestTime":"11-14 16:08:11","open":20.88,"high":22.12,"low":20.2,"amount":13113144,"amplitude":0.094303,"askPrice":21.08,"askSize":800,"bidPrice":21.04,"bidSize":4200,"shortable":3,"etf":0,"ttmEps":-0.945402449294286,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.36,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":0.641342,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":227071600,"roa":"-10.67%","roe":"-68.26%","lyrEps":-1.674119,"volumeRatio":0.641342,"shares":227071600,"dividePrice":0,"high":22.12,"amplitude":0.094303,"preClose":20.36,"low":20.2,"week52Low":5.95,"pbRate":"19.28","psRate":"13.62","week52High":36.5,"institutionHeld":0,"latestPrice":21.04,"committee":0.68,"eps":-1.6741191529099049,"divideRate":0,"volume":612617,"delay":0,"ttmEps":-0.945402449294286,"open":20.88,"prevYearClose":7.38,"prevWeekClose":19.25,"prevMonthClose":21.78,"prevQuarterClose":34.88,"fiveDayClose":19.25,"twentyDayClose":28.5,"sixtyDayClose":24.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post Market","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2025-11-13","current":-22.256841,"percent":0.137931,"low":-38.274716,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"high":-3.10587,"avg":-11.138615,"sd":8.258911,"marketCap":4610921056},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-13","current":-21.952253,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"marketCap":4610921056}],"updateTime":1763110065281},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199400602","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 13% Again Following Strong H1 Performance and Major Investment from TruMed Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1199400602","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199400602?lang=en_us&edition=fundamental","pubTime":"2025-08-21 15:46","pubTimestamp":1755762402,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 13% again, bringing its year-to-date gains to nearly 300%. As of press time, the stock was up 9.26% to HK$27.6, with turnover of HK$45.4 million. On the news front,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1100623558","title":"From Monoclonal to Bispecific Antibodies, From Domestic to Global: How QYUNS-B (02509) Becomes a New Benchmark in the Autoimmune Track?","url":"https://stock-news.laohu8.com/highlight/detail?id=1100623558","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100623558?lang=en_us&edition=fundamental","pubTime":"2025-08-20 10:55","pubTimestamp":1755658500,"startTime":"0","endTime":"0","summary":"The autoimmune sector is emerging as one of the hottest tracks for innovative drug investment, with synchronized warming in both primary and secondary market transactions. Latest statistics show that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1128317238","title":"Hong Kong Stock Alert | QYUNS-B (02509) Surges Over 22% as H1 Revenue Soars with Significant Loss Reduction, Core Product R&D Progresses Smoothly","url":"https://stock-news.laohu8.com/highlight/detail?id=1128317238","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128317238?lang=en_us&edition=fundamental","pubTime":"2025-08-18 17:57","pubTimestamp":1755511042,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) extended its afternoon gains by over 22%, hitting a high of HK$27.7, marking its highest level since September last year. As of press time, the stock was up 22.08% to HK$27.42, with...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2560979859","title":"Qyuns Therapeutics' H1 Loss Narrows; Shares Rise 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560979859","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560979859?lang=en_us&edition=fundamental","pubTime":"2025-08-18 12:01","pubTimestamp":1755489689,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  reported 28.3 million yuan in attributable loss for the half ended June 30, narrowing from a loss of 172.1 million yuan in the year-ago period, according to a Hong Kong bourse filing Friday.Loss per share was 0.13 yuan, compared with 0.79 yuan in the prior year.Revenue rose to 206.5 million yuan from 44.9 million yuan a year earlier, results showed.Shares of the biopharmaceutical company jumped over 6% in morning trade Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","BK4539","02509","LENZ","BK1161"],"gpt_icon":0},{"id":"2560973179","title":"BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560973179","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560973179?lang=en_us&edition=fundamental","pubTime":"2025-08-18 09:15","pubTimestamp":1755479732,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Says To Issue 5 Million Placing Shares At HK$20.0 Per ShareAug 18 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:TO ISSUE 5 MILLION PLACING SHARES AT HK$20.0 PER SHAREFurther company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3U8069:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1139654681","title":"QYUNS-B (02509) Plans to Place 5 Million Shares at Approximately 10.95% Discount, Raising Net Proceeds of About HK$99 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1139654681","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139654681?lang=en_us&edition=fundamental","pubTime":"2025-08-18 08:00","pubTimestamp":1755475220,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on August 18, 2025 (before trading hours), the company entered into a placement agreement with a placing agent. Under the agreement, the placing agent has conditionally...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560611978","title":"Qyuns Therapeutics - to Issue 5 Mln Placing Shares at HK$20.0 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560611978","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560611978?lang=en_us&edition=fundamental","pubTime":"2025-08-18 07:47","pubTimestamp":1755474452,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250817:nFWN3U8069:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1124610552","title":"QYUNS-B (02509) Announces Interim Results with Revenue of RMB 206 Million, Up 359.69% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1124610552","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124610552?lang=en_us&edition=fundamental","pubTime":"2025-08-15 22:08","pubTimestamp":1755266902,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced its results for the six months ended June 30, 2025. The group achieved revenue of RMB 206 million, representing a year-on-year increase of 359.69%. R&D expenses totaled RMB...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2559914912","title":"BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914912","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914912?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:45","pubTimestamp":1755265526,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics HY Revenue RMB206.5 MillionAug 15 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:HY REVENUE RMB206.5 MILLIONHY LOSS RMB30.9 MILLION VERSUS LOSS OF RMB183.1 MILLIONFurther company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"2559912999","title":"Qyuns Therapeutics - Hy Revenue RMB206.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2559912999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559912999?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:43","pubTimestamp":1755265390,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"1167217522","title":"QYUNS-B (02509) Appoints Feng Zhiwei as Chief Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1167217522","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167217522?lang=en_us&edition=fundamental","pubTime":"2025-08-15 16:52","pubTimestamp":1755247971,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that to adopt high standards of corporate governance, the board of directors has designated independent non-executive director Mr. Feng Zhiwei to serve as chief independent non-executive director, effective from August 15, 2025.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2557315321","title":"Qyuns Therapeutics' Psoriasis Drug Enters Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2557315321","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557315321?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:55","pubTimestamp":1754398538,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics'  QX004N for the treatment of psoriasis and Crohn's disease entered a phase III clinical trial, a Tuesday Hong Kong bourse filing said.The biotechnology company also received a payment of 58 million yuan from Hansoh Pharmaceutical  for reaching the phase III trial under a license agreement related to the drug.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","LENZ","BK4134","BK4007","BK1583","02509","BK1191","BK1589","III","03692","BK4139","BK1161"],"gpt_icon":0},{"id":"1139907820","title":"Hong Kong Stocks Movement | QYUNS-B (02509) Surges Over 8% Intraday, Stock Price Accumulates Nearly 40% Gain in Past Month with Leading Position in Domestic Autoimmune Dual Antibody Layout","url":"https://stock-news.laohu8.com/highlight/detail?id=1139907820","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139907820?lang=en_us&edition=fundamental","pubTime":"2025-08-01 10:58","pubTimestamp":1754017129,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) surged over 8% intraday, reaching a high of HK$22.15, hitting its highest level since October last year. The stock has accumulated nearly 40% gains over the past month. As of press...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2549304485","title":"Qyuns Therapeutics Subscribes to Two Wealth Management Products from Shanghai Pudong Development Bank; Shares Fall 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549304485","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549304485?lang=en_us&edition=fundamental","pubTime":"2025-07-07 13:12","pubTimestamp":1751865176,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said it would funnel 120 million yuan in idle funds to two wealth management products offered by Shanghai Pudong Development Bank , according to a Friday Hong Kong bourse filing.Shares fell over 1% in morning trade Monday.The first product is worth 60 million yuan with a guaranteed yield of 0.70% and a floating mid-range yield of 0% or 0.95% or a 1.15% high-range floating yield.The second product is worth 60 million yuan with a guaranteed yield of 0.70% and a floating mid-range yield of 0% or 1.20% or a high-range yield of 1.40%, the filing said.Both products will mature on Oct. 9.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0012","BK0188","BK0183","US2Y.BOND","BK0278","SGXZ49509284.SGD","BK0086","SGXZ81163826.USD","LU0469268626.HKD","US7Y.BOND","BK4007","US12M.BOND","600000","US5Y.BOND","US6M.BOND","US30Y.BOND","02509","BK0015","US10Y.BOND","LENZ","BK4539","BK0187","BK0201","LU1934453819.USD","LU1979443071.USD","BK4139","LU1808992512.USD","US3Y.BOND","BK1161","BK0028"],"gpt_icon":0},{"id":"2548392844","title":"BRIEF-Qyuns Therapeutics Subscribes To Wealth Management Products With Principal Amount RMB60 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2548392844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548392844?lang=en_us&edition=fundamental","pubTime":"2025-07-04 23:21","pubTimestamp":1751642507,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Subscribes To Wealth Management Products With Principal Amount RMB60 MlnJuly 4  - Qyuns Therapeutics Co Ltd 2509.HK:SUBSCRIBES TO WEALTH MANAGEMENT PRODUCTS WITH PRINCIPAL AMOUNT OF RMB60 MILLIONFurther company coverage: 2509.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250704:nFWN3T00OH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2544126132","title":"Qyuns Therapeutics Co. Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544126132","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544126132?lang=en_us&edition=fundamental","pubTime":"2025-06-20 18:33","pubTimestamp":1750415597,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co. Ltd. held its annual general meeting on June 20, 2025. All proposed resolutions were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief on June 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL26JZnz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}